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Abstract. – BACKGROUND AND OBJECTIVES:
The current investigation was carried out to ex-
plore the pharmacological basis of the crude ex-
tract of Conyza bonariensis (Cb.Cr) for its use in
constipation and diarrhea.
MATERIALS AND METHODS: The plant ex-
tract of Conyza bonariensis (C. bonariensis) was
prepared, isolated guinea-pig ileum and rabbit
jejunum preparations were used to evaluate its
gut modulator effects.
RESULTS: The Cb.Cr (0.3-10 mg/mL) exhibited
spasmogenic effect in isolated guinea-pig ileum
preparation, which was about 19-84% of the acetyl-
choline maximum. Pretreatment of the tissues with
atropine (0.1 µM) abolished the contractile effect,
similar to acetylcholine. Among the fractions, only
the butanol fraction exhibited atropine sensitive
contractile effect. In isolated rabbit jejunum prepa-
rations, Cb.Cr produced appreciable atropine-sen-
sitive spasmogenic effect at lower concentrations
(0.03-0.3 mg/mL) followed by spasmolytic effect at
next higher concentration (1.0 and 3.0 mg/mL).
Cb.Cr caused an inhibition of the high K+ in-
duced contraction in isolated rabbit jejunum
preparation with EC50 value of 0.62 mg/mL. Simi-
larly, verapamil, a standard calcium blocker, inhib-
ited high K+ induced contraction in isolated rabbit
jejunum preparations. Cb.Cr caused a right ward
shift in the Ca++ concentration response curve,
similar to verapamil. Among various fractions of
C. bonariensis, only hexane and ethylacetate frac-
tions showed spasmolytic effects.
CONCLUSIONS: The crude extract of C.
bonariensis contains spasmogenic and spas-
molytic constituents, which explains its medici-
nal use in constipation and diarrhea.
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Introduction
Conyza bonariensis is a perennial native plant of
the family Asteraceae. It plays an important role in
supplying crude proteins and contributes a signifi-
cant proportion of herbage fed to ruminant. This
weed is widely available in local range lands of In-
do-Pak1 and Middle East2. Moreover, the plant is
also commonly cultivated as an ornamental plant
in gardens. In the South Asian traditional system of
medicine, various parts of the plant are being used
in a variety of ailments. Infusion of the petals is
given as refrigerant and demulcent. Leaves are
used as laxative, root is used in diarrhoea3-4, cough3
while flowers are considered as aphrodisiac, emol-
lient5, and in gastrointestional problems including
diarrhea6. Phytochemical studies of C. bonariensis
revealed the presence of several bioactive con-
stituents including flavonoids, flavonoid glyco-
sides, cyanin glycoside, taraxeryl acetate, β-sitos-
terol, campesterol, stigmasterol, ergosterol7, cyclo-
propenoids8 and anthocyanin pigments5.
The plant has also been evaluated pharmaco-
logically for the presence of anticonvulsant4, an-
titumor9, hypoglycaemic10 and estrogenic11 activ-
ities. This study was aimed at exploring the phar-
macological rationale of C. bonariensis for its
medicinal use in constipation and diarrhea.
Materials and Methods
Plant Materials
The whole plant of Conyza bonariensis (L.)
Cronq. (Asteraceae) was collected from Oghi,
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Mansehra, Pakistan, in November 2002, and iden-
tified by Mr. Jan Alam (Taxanomist) at the De-
partment of Botany, University of Karachi, Pak-
istan. A voucher specimen (KUH G. H. No.
68220) has been deposited at the herbarium of the
above Department.
Extraction and Fractionation
The air dried whole plant of Conyza bonarien-
sis (35 kg) was exhaustively extracted with
MeOH (50 L×3) at room temperature. The ex-
tract was evaporated to yield the residue (815 g),
which was partitioned between n-hexane (110 g),
CHCl3 (90 g), EtOAc (95 g), n-BuOH (495 g)
and water (25 g).
Drugs and Animals
Acetylcholine perchlorate, atropine sulphate,
potassium chloride, histamine diphosphate salt
and verapamil hydrochloride, were purchased
from Sigma Chemicals Co, St Louis, MO, USA
and pyrilamine maleate USP grade was pur-
chased from RB Industries Inc., Chicago, IL,
USA. All other chemicals used were of the high-
est analytical grade available. All drugs were dis-
solved in distilled water and dilutions were made
fresh in normal saline (0.9% sodium chloride) on
the day of experiment.
Animals used in this study were housed at the
Animal House of The Aga Khan University, main-
tained at 23-25°C and were given a standard diet
and tap water. Experiments performed complied
with the rulings of the Institute of Laboratory Ani-
mal Resources, Commission on Life Sciences, Na-
tional Research Council (NRC, 1996). Rabbits (1.0-
1.5 kg) and guinea pigs (500-600 g) of local breed
and either sex were used for this study. Animals
had free access to water but food was withdrawn 24
hours prior to the experiment. Rabbits were sacri-
ficed by a blow on the back of the head and guinea
pigs were sacrificed by cervical dislocation.
Isolated Tissue Preparations
The spasmogenic and spasmolytic activities of
the plant material were studied using isolated
guinea-pig ileum and rabbit jejunum prepara-
tions, as described previously12. Respective seg-
ments of 2 cm length were suspended in a 10 mL
tissue baths containing Tyrode’s solution, aerated
with a mixture of 95% oxygen and 5% carbon
dioxide and maintained at 37oC. The composition
of the Tyrode’s solution was: KCl 2.68, NaCl
136.9, MgCl2 1.05, NaHCO3 11.90, NaH2PO4
0.42, CaCl2 1.8 and glucose 5.55 mM. Intestinal
responses were recorded isotonically using Bio-
Science transducers and oscillographs. Each tis-
sue was allowed to equilibrate for at least 30 min
before the addition of any drug.
Under these experimental conditions, guinea
pig ileum behaved as a quiescent preparation and
is considered more useful for spasmogenic activ-
ity13, whereas rabbit jejunum exhibits sponta-
neous rhythmic contractions, allowing to test the
relaxant (spasmolytic) activity directly without
the use of an agonist14. The contractile effect of
the test material was assessed as the percent of
the maximum effect produced by the control
drug, acetylcholine (1.0 µM).
Determination of calcium antagonist activity:
To assess whether the spasmolytic activity of the
test substances, was through calcium channel
blockade (CCB), K+, as KCl, was used to depolar-
ize the preparations according to method15. High
K+ (80 mM) was added to the tissue bath, which
produced a sustained contraction. Test materials
were then added in a cumulative fashion to obtain
concentration-dependent inhibitory responses16.
The relaxation of intestinal preparations, precon-
tracted with K+ (80 mM) was expressed as percent
of the control response mediated by K+.
To confirm the calcium antagonist activity of
test substances, the tissue was allowed to stabilize
in normal Tyrode’s solution, which was then re-
placed with Ca++-free Tyrode’s solution containing
EDTA (0.1 mM) for 30 min in order to remove
Ca++ from the tissues. This solution was further re-
placed with a K+-rich and Ca++-free Tyrode’s solu-
tion, having the following composition: KCl 50,
NaCl 91.04, MgCl2 1.05, NaHCO3 11.90,
NaH2PO4 0.42, glucose 5.55 and EDTA 0.1 mM.
Following an incubation period of 30 min, control
concentration-response curves (CRCs) of Ca++
were obtained. When the control CRCs of Ca++
were found super-imposable (usually after two cy-
cles), the tissue was pretreated with the plant ex-
tract for 60 min to test a possible CCB effect. The
CRCs of Ca++ were developed in the presence of
different concentrations of the test material.
Statistical Analysis
The data is expressed in mean ± standard error
of the mean (SEM). The median effective con-
centrations (EC50 values) were obtained using
Graph Pad Prism version 4. Data was analyzed
by one way ANOVA followed by the Student-
Newman-Keuls multiple comparison test when
significant difference were present. p < 0.05 was
considered statistically significant.
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Figure 1. Tracings showing the dose dependent contractile effect of the crude extract of Conyza bonariensis (Cb.Cr) in the ab-
sence and presence of atropine in the isolated guinea-pig ileum preparations (A). Acteycholine (ACh) was used as positive control
and concentration-response curve for the spasmogenic effects of Cb.Cr (B) and butanol fraction; BUOH (C) without and with at-
ropine in isolated guinea-pig ileum preparations. Data are mean ± SEM of percentage of ACh maximum contractions (n=6).
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sensitive contractile effect (Figure 1C) in isolated
guinea-pig ileum preparations, while other frac-
tions, such as, ethylacetate (EtAc) and hexane
(Hex) were found without any contractile effect
at the maximum concentrations used.
The Cb.Cr and its fractions were further stud-
ied in isolated rabbit jejunum preparations. When
tested on spontaneous contractions, Cb.Cr (0.3-
3.0 mg/mL) caused relaxation of the spontaneous
contraction of isolated rabbit jejunum prepara-
tion with an appreciable spasmogenic effect at
lower concentrations of 0.03-0.3 mg/mL (Figure
2). Pre-treatment of tissue with atropine (0.1 µM)
completely abolished the spasmogenic effect of
Results
The plant extracts of C. bonariensis and its
various fractions were evaluated for its effect in
isolated rabbit jejunum and guinea pig ileum
preparations. In isolated guinea-pig ileum prepa-
ration, Cb.Cr caused concentration-dependent
contractile effect, which was about 19-84% of
acetylcholine maximum effect (Figure 1A and
B). Pretreatment of the tissues with atropine (0.1
µM), abolished the contractile effect of the crude
extract, similar to that of acetylcholine. Among
the fractions studied, only the butanol fraction of
C. bonariensis (Cb.BUOH) exhibited atropine
555
Spasmogenic and spasmolytic effect of Conyza bonariensis
the plant extract (Figure 2) and relaxation was
obtained at significantly (p < 0.001) lower con-
centration with respective EC50 values, in the ab-
sence and presence of atropine, were 0.44 and
0.05 mg/mL (Figure 3 A).
Cb.Cr caused a concentration-dependent relax-
ation of K+-induced contractions with EC50 of
0.62 mg/mL (Figure 3A). Similar to the effects
of Cb.Cr, Verapamil, used as a reference stan-
dard produced marked inhibition of spontaneous
and high K+-induced contractions in isolated rab-
bit jejunum preparation (Figure 3B).
Activity-directed fractionation revealed that
the ethylacetate fraction of C. bonariensis
(Cb.EtAc) antagonized spontaneous and high K+-
induced contractions in rabbit jejunum prepara-
tions with EC50 of 0.85 mg/mL (Figure 3 C).
Similarly hexane fraction of C. bonariensis
(Cb.Hex) caused relaxation of the spontaneous
and high K+-induced contractions in isolated rab-
bit jejunum preparations at comparatively lower
concentrations than the parent crude extract with
EC50 value of 0.25 mg/mL (Figure 3D). Cb.Cr
caused a rightward shift in the Ca++ concentra-
tion-response curves, constructed in the Ca++-free
and K+ rich medium (Figure 4A), similar to vera-
pamil (Figure 4B).
Discussion
This study was aimed at exploring the pharma-
cological basis for the use of Conyza bonariensis
in the management of constipation and diarrhea.
Isolated guinea-pig preparation was used to test
the possible contractile effect of the crude extract
of C. bonariensis, which is considered more suit-
able preparation for the demonstration of spas-
mogenic effect12. Cb.Cr caused concentration-de-
pendent contractile effect in isolated guinea-pig
ileum preparation. Pretreatment of tissues with
atropine (0.1 µM), abolished the contractile ef-
fect of the plant extract, similar to that of acetyl-
choline, indicating the involvement of choliner-
gic receptors in the observed contractile effect of
the plant extracts. Acetylcholine is a neurotrans-
mitter released by the parasympathetic nervous
system, mediates its action in the gut by stimula-
Figure 2. Tracing showing the spasmolytic effect of crude extract of Conyza bonariensis on spontaneously contracting isolat-
ed rabbit jejunum preparations in the absence and presence of atropine.
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Figure 3. Inhibitory effect of the crude extract of Conyza bonariensis; Cb.Cr (A), verapamil (B), ethylacetate; Cb.EtAc (C)
and hexane; Cb.Hex fraction (D) on spontaneous and high K+-induced contractions in isolated rabbit jejunum preparations.
Values are mean ± SEM (n=4-6). ***p < 0.001 compared to spontaneous contractions without atropine.
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Figure 4. Effect of different concentration of (A) the crude extract of Conyza bonariensis (Cb.Cr) ad (B) verapamil on Ca++
concentration-response curves in isolated rabbit jejunum preparations. Values are mean ± SEM (n= 4-6). **p < 0.01, ***p <
0.001 compared to respective controls.
%
o
f
co
n
tr
o
lm
ax
im
u
m
%
o
f
co
n
tr
o
lm
ax
im
u
m
A B
tion of muscarinic M3 receptor subtypes and at-
ropine blocks all muscarinic receptor sites.
Acetylcholine plays an important physiological
role to regulate the peristaltic movements of the
gut17. Cholinergic agents are known to increase
the secretory and motor activity of the gut18. The
observed contractile effect of the crude extract,
similar to that of acetylcholine, may explain the
medicinal use of C. bonariensis in constipation18.
However, the co-existence of other mechanisms
cannot be excluded completely.
Activity guided fractionation study revealed
that contractile constituents of C. bonariensis
were concentrated in butanol fraction which can
be used effectively in the treatment of constipa-
tion. The crude extract and its fractions were fur-
ther studied in isolated rabbit jejunum prepara-
tions. C. bonariensis plant extract produced relax-
ation of the spontaneous contraction of isolated
rabbit jejunum preparation with an appreciable
spasmogenic effect at lower concentrations, sug-
gesting that the plant extract has got spasmogenic
effect which is accompanied by a spasmolytic ef-
fect. Similar to the effect of C. bonariensis in the
guinea pig ileum preparation, the spasmogenic ef-
fect of the crude extract was abolished with pre-
treatment of the tissue with atropine (0.1 µM), an
antimuscarinic agent19. In atropine pre-treated tis-
sues the relaxation was obtained at lower concen-
tration. The relaxant effect of C. bonariensis in
the absence and presence of atropine were signifi-
cantly different from each other, indicating the
presence of spasmogenic and spasmolytic con-
stituents in the plant extracts.
We have previously observed that the spas-
molytic constituents present in medicinal plants
usually mediate their effect through calcium
channel blockade (CCB) properties20-21. To see
whether the spasmolytic effect of C. bonariensis
observed in this study is mediated through CCB,
a high concentration of K+ (80 mM) was used
which caused sustained contraction. The crude
extract caused a concentration-dependent relax-
ation of K+-induced contractions, similar to vera-
pamil. K+ at high concentrations (>30 mM) is
known to cause smooth muscle contractions
through opening of voltage-dependent slow Ca++
channels, thus allowing influx of extracellular
Ca++ causing a contractile effect22. Thus the in-
hibitory effect of the plant extract against K+-in-
duced contractions can be visualized as the CCB.
The presence of calcium antagonist(s) in the
plant extract was confirmed when it caused a
rightward shift in the Ca++ concentration-re-
sponse curves, constructed in the Ca++-free and
K+ rich medium, similar to that caused by vera-
pamil, a standard Ca channel blocker22. Interest-
ingly CCBs are known to be useful as antispas-
modic and antidiarrhoeal23. Activity-directed
fractionation studies revealed that the relaxant
constituents of C. bonariensis plant extract were
concentrated in the hexane and ethylacetate frac-
tion. Both these fraction caused a significant re-
laxant effect in spontaneous and high K+-induced
contractions in isolated rabbit jejunum prepara-
tions. In contrast to their parent crude extract, the
hexane and ethylacetate fractions of C. bonarien-
sis did not produce any contractile effect in the
isolated rabbit jejunum preparations.
Conclusions
The data from the present study indicate that
the crude extract of C. bonariensis contains spas-
mogenic constituents, which are separated into
the butanol fraction and spasmolytic constituents,
concentrated in the ethylacetate and hexane frac-
tions. The spasmogenic activity of the plant ex-
tract was similar to acetylcholine while the spas-
molytic effect resembled calcium channel block-
ers. Moreover, theses finding validate the medic-
inal use of the C. bonariensis in constipation and
diarrhea.
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